Metastatic | Non-metastatic | p value | |
Patients n (%) | 6 (21.4) | 22 (78.6) | |
n (%) of patients by affected bones | |||
Spine | 4 (66.7) | 0 (0.0) | |
other bones | 2 (33.3) | 0 (0.0) | |
Number of metastatic sites | |||
PSA < 100 ng/ml | ≤2 | 0.10 |